Rasha Al-Lamee

Jun 12, 2024 | medscape.co.uk | Rasha Al-Lamee

ORBITA-2 Investigated the Use of Percutaneous Coronary Intervention in Patients with Stable Angina Receiving Little or No Antianginal Medication.

Apr 16, 2024 | healio.com | Scott Buzby |Richard Smith |Rasha Al-Lamee

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways:A coronary sinus reducer reduced the frequency of angina events for patients with significant CAD. However, the reducer did not have impact on a significant myocardial perfusion.

Apr 8, 2024 | uscjournal.com | Rasha Al-Lamee |Michael Anne Foley |Harriette Van Spall |James L. Januzzi

ACC.24 — Investigators, Dr Rasha K Al-Lamee and Dr Michael Foley (Imperial College London, UK) joined us to discuss the ORBITA COSMIC trial (NCT04892537). This randomized, double-blinded, placebo-controlled trial investigated the effects of coronary sinus reducer (CSR) as compared to placebo on myocardial perfusion via MRI, exercise duration, and symptoms in patients with refractory angina and ischemia.

Nov 11, 2023 | healio.com | Erik Swain |Richard Smith |Samin Sharma |Rasha Al-Lamee

Samin K. Sharma, MD, FACC, FSCAIThe original ORBITA trial created so much uncertainty among interventionalists that maybe angioplasty doesn’t work. Its primary outcome was exercise capacity at 6 weeks, and the difference between the PCI and sham groups was only 16 seconds, which missed the performance goal, so therefore the trial was negative. But now, in ORBITA-2, the researchers wanted to see what the quality of life, angina episodes and additional angina medications would be with PCI vs.

Sep 13, 2023 | medscape.com | Robert Byrne |Mb Bch |Rasha Al-Lamee

Recorded August 28, 2023. This transcript has been edited for clarity. Robert A. Byrne, MB BCh, PhD: Hello and welcome. My name is Robert Byrne. I'm a cardiologist working in Dublin, Ireland. I'm very pleased to be here at ESC 2023 in Amsterdam. I'm delighted to be joined by a friend and colleague, Rasha Al-Lamee. Rasha Al-Lamee, MBBS, MA, PhD: Hi, Rob. Byrne: Rasha is from London in the UK.